Moreover, the clinical applicability of these findings is quite significant because patients with melanoma often have multiple options for management of systemic disease from BRAF inhibitors to observation (in cases of no detectable extracranial disease).
← all excerpts
Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain Metastases.
1
—
—